FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 334:189-190 January 18, 1996 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Each year 60,000 people in the United States die of colorectal cancer. Current approaches to screening can reduce that number by perhaps one third. One clinical trial in the United States has demonstrated a reduction in mortality associated with yearly screening with the use of rehydrated Hemoccult II slides,¹ and two of three European trials will provide data about non-rehydrated slides.^2,3,4 Sigmoidoscopy also appears to be effective.⁵ At present, screening for colorectal cancer is performed infrequently, although for more than a decade it has been widely, if not universally,⁶ recommended for people over the age of 50 years.

Fecal occult-blood . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Allison, J. E., Tekawa, I. S., Ransom, L. J., Adrain, A. L., Ransohoff, D. F., Lang, C. A. (1996). Improving the Fecal Occult-Blood Test. NEJM 334: 1607-1608 [Full Text]